A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

NCT02512315 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel (DOC)
DRUG: Cisplatin (DDP)
RADIATION: Concurrent chemoradiation (CCRT)

Sponsor

Sun Yat-sen University